Myasthenia Gravis Disease Market Study, Synthesis 2019 Competitive Analysis based on types and application, Forecast to 2023

Myasthenia Gravis Disease Market Research Report: Diagnosis (Imaging, Blood Tests, Electrodiagnostic, Edrophonium Test), Treatment (Medication, Surgery, HSCT), End-User (Hospitals, Clinics, Academic Research Institutes) – Global Forecast Till 2023

Market Scenario

The global myasthenia gravis disease market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominates the global myasthenia gravis disease market owing to the growing prevalence of muscular dystrophies such as congenital muscular dystrophies, distal muscular dystrophy, Becker muscular dystrophies, and others along with the extensive demand for diagnostic and treatment services. Moreover, major companies are launching FDA approved drugs thus increasing the commercial access to these drugs worldwide.

The global market for the myasthenia gravis disease is expected to grow at a CAGR of approximately 7.5% during 2017 to 2023.

Avail Sample Copy at https://www.marketresearchfuture.com/sample_request/5843

Segmentation

The global myasthenia gravis disease market has been segmented on the basis of diagnosis, treatment, and end-user.

On the basis of diagnosis, the global myasthenia gravis disease market can be segmented into imaging, blood tests, electrodiagnostic, edrophonium test, pulmonary function test, and others. The imaging segment is classified into X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and others.

On the basis of treatment, the global myasthenia gravis disease market can be segmented into medication, surgery, autologous Hematopoietic Stem Cell Transplantation (HSCT), plasmapheresis and intravenous immunoglobulin, and others.

The medication segment is divided into acetylcholinesterase inhibitors, immunosuppressant drugs, steroids, and others. The acetylcholinesterase inhibitors are classified into atropine, neostigmine, pyridostigmine, and others. The immunosuppressant drugs are further divided into prednisone, azathioprine, mycophenolate mofetil, tacrolimus, and rituximab. The steroids are further divided into prednisone and others. The surgery is finally divided into thymectomy and others.

On the basis of end-user, the global myasthenia gravis disease market is segmented into hospitals, clinics, academic research institutes, and others.

Key Players

Some of the key players in the global myasthenia gravis disease market are Valeant Pharmaceuticals International (U.S.), Sun Pharmaceuticals Industries Ltd. (India), Piramal Healthcare (India), Novartis Pharmaceuticals Corporation (Switzerland), Apotex Corporation (Canada), Teva Pharmaceutical Industries Ltd. (Israel), RPG Life Sciences (India), Cipla (India), F. Hoffmann Roche La Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), Biogen Inc. (U.S.), and AbbVie Inc. (U.S.), GlaxoSmithKline plc (UK), Fresenius Kabi (Germany), and others.

Regional Analysis:

The global myasthenia gravis disease market consists of four regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas accounted for the largest market share of the global myasthenia gravis disease market owing to the growing number of drug manufacturers, increasing awareness about the long-term effects of muscle dystrophy, and rising government funding for the treatment of this disease in the region. Moreover, the U.S. contributes to a significant market share in the global pharmaceutical industry.

Browse Complete Premium Report at https://www.marketresearchfuture.com/reports/myasthenia-gravis-disease-market-5843

The European myasthenia gravis disease market is the second largest market followed by the Asia Pacific region.

The Asia Pacific region is expected to emerge as the fastest growing market for the global myasthenia gravis disease market due to the growing awareness about neuromuscular disorders and vast improvement in health care reforms in countries such as Malaysia, India, Indonesia, and China.

The Middle Eastern region is expected to grow at a steady pace owing to factors such as the extensive development of the healthcare infrastructure and rising R&D activities in the healthcare sector.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.